A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients

Our aim was to clarify the optimum pre-ablative thyroid-stimulating hormone (TSH) level for initial radioiodine remnant ablation (RRA) in patients with differentiated thyroid carcinoma (DTC). From December 2015 to May 2019, 689 patients undergone RRA at Nuclear Medicine Department, Second Hospital o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Juan, Yun, Canhua, Cao, Jingjia, Ding, Shouluan, Shao, Chunchun, Wang, Lina, Huang, Fengyan, Jia, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809467/
https://www.ncbi.nlm.nih.gov/pubmed/33446744
http://dx.doi.org/10.1038/s41598-020-80015-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809467/
https://www.ncbi.nlm.nih.gov/pubmed/33446744
http://dx.doi.org/10.1038/s41598-020-80015-8

Ejemplares similares